Exposure of iron foundry workers to polycyclic aromatic hydrocarbons : benzo pyrene-albumin adducts and 1-hydroxypyrene as biomarkers for exposure
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
<record>
<leader>00000nab a2200000 i 4500</leader>
<controlfield tag="001">MAP20071020930</controlfield>
<controlfield tag="003">MAP</controlfield>
<controlfield tag="005">20080418120413.0</controlfield>
<controlfield tag="007">hzruuu---uuuu</controlfield>
<controlfield tag="008">940919e19940801gbr|||| | |00010|eng d</controlfield>
<datafield tag="040" ind1=" " ind2=" ">
<subfield code="a">MAP</subfield>
<subfield code="b">spa</subfield>
</datafield>
<datafield tag="084" ind1=" " ind2=" ">
<subfield code="a">873</subfield>
</datafield>
<datafield tag="245" ind1="1" ind2="0">
<subfield code="a">Exposure of iron foundry workers to polycyclic aromatic hydrocarbons</subfield>
<subfield code="b">: benzo pyrene-albumin adducts and 1-hydroxypyrene as biomarkers for exposure</subfield>
<subfield code="c">O. Omland... [et al.]</subfield>
</datafield>
<datafield tag="520" ind1=" " ind2=" ">
<subfield code="a">Increased risk of lung cancer has been shown to occur in several studies of iron foundry workers. Polycyclic aromatic hydrocarbons may be an aetiological factor. Exposure to carcinogenic chemicals can be evaluated by measuring covalent binding with macromolecular targets, DNA, and proteins. As target tissue is not ussually available several surrogate materials have been studied. 1-Hydroxypyrene, a urinary metabolite of pyrene, has recnetly been used as to monitor PAH exposure in humans</subfield>
</datafield>
<datafield tag="650" ind1="1" ind2="1">
<subfield code="0">MAPA20080576615</subfield>
<subfield code="a">Medicina laboral</subfield>
</datafield>
<datafield tag="650" ind1="1" ind2="1">
<subfield code="0">MAPA20080619480</subfield>
<subfield code="a">Enfermedades profesionales</subfield>
</datafield>
<datafield tag="650" ind1="1" ind2="1">
<subfield code="0">MAPA20080550981</subfield>
<subfield code="a">Fundición</subfield>
</datafield>
<datafield tag="650" ind1="1" ind2="1">
<subfield code="0">MAPA20080541286</subfield>
<subfield code="a">Hierro</subfield>
</datafield>
<datafield tag="650" ind1="1" ind2="1">
<subfield code="0">MAPA20080593780</subfield>
<subfield code="a">Sustancias químicas</subfield>
</datafield>
<datafield tag="650" ind1="1" ind2="1">
<subfield code="0">MAPA20080610579</subfield>
<subfield code="a">Enfermedades pulmonares</subfield>
</datafield>
<datafield tag="650" ind1="1" ind2="1">
<subfield code="0">MAPA20080540500</subfield>
<subfield code="a">Cáncer</subfield>
</datafield>
<datafield tag="650" ind1="1" ind2="1">
<subfield code="0">MAPA20080630195</subfield>
<subfield code="a">Hidrocarburo aromático policíclico</subfield>
</datafield>
<datafield tag="700" ind1="1" ind2=" ">
<subfield code="0">MAPA20080015466</subfield>
<subfield code="a">Omland, O.</subfield>
</datafield>
<datafield tag="740" ind1="0" ind2=" ">
<subfield code="a">Occupational and environmental medicine</subfield>
</datafield>
<datafield tag="773" ind1="0" ind2=" ">
<subfield code="t">Occupational and environmental medicine</subfield>
<subfield code="d">London and Margate</subfield>
<subfield code="g">nº 8, August 1994 ; p. 513-518</subfield>
</datafield>
</record>
</collection>